NFKB1 and acute lymphoblastic leukemia: The inhibitor of nuclear translocation of NF-κB, BAY 11–7082, was only effective in NALM6 mono-culture (Figure 6D), indicating that activated WNT and cytokine signaling pathways represent potential targets to eradicate B-ALL cells adherent to MSCs.